CIBC World Markets Healthcare Conference In Brief
This article was originally published in The Gray Sheet
Executive Summary
Integra finds Newdeal for foot repair: Acquisition of French reconstructive surgery device maker Newdeal for $50 mil. Nov. 14 adds specialty implants and instruments for foot and angle surgery. Key offerings include Bold screws, Hallu-Fix plates and Hintegra total ankle prostheses sold through direct reps in France, Belgium and the Netherlands, as well as distributors in the U.S. and other countries. Newdeal sales totaled about $18 mil. in 2003. Integra expects the devices to dovetail with its own regenerative offerings, including Integra dermal regeneration templates and wound dressings, and NeuraGen and NeuraWrap nerve repair products - which can be used to treat foot and ankle wounds. During a Nov. 9 session of the CIBC meeting in New York, Integra CEO Stuart Essig noted that the firm's peripheral nerve injury offerings were "growing quickly," aided by the September launch of the 510(k)-cleared NeuraWrap collagen nerve repair conduit for injured, compressed or scarred nerves. The line includes NeuraGen, launched in 2001 for completely severed nerves...
|
Integra finds Newdeal for foot repair: Acquisition of French reconstructive surgery device maker Newdeal for $50 mil. Nov. 14 adds specialty implants and instruments for foot and angle surgery. Key offerings include Bold screws, Hallu-Fix plates and Hintegra total ankle prostheses sold through direct reps in France, Belgium and the Netherlands, as well as distributors in the U.S. and other countries. Newdeal sales totaled about $18 mil. in 2003. Integra expects the devices to dovetail with its own regenerative offerings, including Integra dermal regeneration templates and wound dressings, and NeuraGen and NeuraWrap nerve repair products - which can be used to treat foot and ankle wounds. During a Nov. 9 session of the CIBC meeting in New York, Integra CEO Stuart Essig noted that the firm's peripheral nerve injury offerings were "growing quickly," aided by the September launch of the 510(k)-cleared NeuraWrap collagen nerve repair conduit for injured, compressed or scarred nerves. The line includes NeuraGen, launched in 2001 for completely severed nerves.... Cardiac Science/GE Healthcare expand partnership: Revised multi-year distribution agreement calls for GE's acute-care hospital sales team to begin marketing Cardiac Science Powerheart -branded automated external defibrillators (AEDs) and CRM fully-automatic in-hospital defibrillator-monitors domestically and in Canada, Cardiac Science CEO Raymond Cohen announces at the CIBC meeting Nov. 9. The deal includes the latest version of the Powerheart, AED G3 PRO , 510(k)-cleared in August, for which original equipment manufacturer shipments to GE commenced in October. Under the firms' initial July 2003 agreement, GE markets Cardiac Science technology outside the U.S. under its own label (1 'The Gray Sheet' Aug. 4, 2003, In Brief).... Ossur seeks CE mark for "bionic leg": Orthotics and prosthetics maker is waiting to hear back from European regulatory authorities after submitting CE mark documentation for the "active" prosthesis, the Icelandic firm says. Touted as active and "predictive," rather than "passive" or "reactive," the Ossur bionic leg is unique in that it generates its own biomechanical power, Ossur claims. A network of sensors on the prosthesis and placed on a person's sound leg, communicating with an AI module, enable real-time movement anticipation for the prosthetic leg, the firm explains. "It will learn the gait of the user," CEO Jon Sigurdsson told CIBC meeting attendees Nov. 8. R&D partner Victhom Human Bionics developed the technology. Ossur says it is planning trials to collect data and anticipates marketing in North America, but notes that it has yet to discuss potential regulatory requirements with FDA.... |